The North America healthcare contract research organizations (CRO) services market is expected to reach US$ 40,863.26 million by 2027 from US$ 19,498.79 million in 2019. The market is estimated to grow at a CAGR of 9.9% during 2020–2027.
The healthcare contract research organizations (CRO) services market is growing primarily due to the growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the North America region. Factors such as stringent regulations for approval of drugs damage the growth of the market. Additionally, rising biosimilars and biologics market and globalization of clinical studies are likely to fuel the growth of the healthcare contract research organizations (CRO) services market during the forecast period.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Exponentially developing healthcare infrastructure and increasing adoption of advanced technologies by several countries have led to the globalization of clinical studies during the past decade. Additionally, economic globalization in developed countries play a key role in globalization. For instance, according to a study published in the International Journal of Clinical Trials in 2016, the number of countries, which serve as clinical study locations outside the US, has doubled in the last 10 years.
Furthermore, according to a data published by clinicaltrails.gov, as of June 2020, an estimated 61.0% of the total studies were recruited at out of the US locations. Factors such as cost optimization, infrastructure availability, patient recruitment rate, government regulations, and market potential offer a major contribution for the transition from US to other countries. Globalization of these clinical studies has opened new avenues and market potential for CROs.
North America is witnessing the growing number of COVID-19 cases. Due to the outbreak of COVID-19 pandemic there is an increased need for therapeutic or vaccine for this highly contagious viral disease. Hence, more COVID-19 clinical trials are being planned and initiated, whereas, the large number of clinical trials in US for non- COVID-19 indications are being delayed. Therefore, it is likely to affect the healthcare contract research organizations (CRO) services market owing to the above mention points.
Based on service type, the healthcare contract research organizations (CRO) services market is further segmented into early phase development, laboratory services, consulting services, and clinical research services. Early phase development market is further categorized into discovery studies, chemistry, marketing & manufacturing, and preclinical market. The laboratory services segment is further sub segmented as bio-analytical testing and analytical testing. The clinical research services segment is further bifurcated into phase I, phase II, phase III, and phase IV. In 2019, the clinical research segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing clinical trials and growing R&D investment.
A few of the significant secondary sources associated with the North America Healthcare contract research organizations (CRO) services market report World Health Organization (WHO), National Institutes of Health (NIH), National Cancer Institute, Centers for Disease Control and Prevention (CDC), Asthma and Allergy Foundation of America (AAFA), and others.
TABLE OF CONTENTS
1. Introduction 17 1.1 Scope of the Study 17 1.2 Research Report Guidance 17 1.3 Market Segmentation 19 1.3.1 North America Healthcare contract research organizations (CRO) services Market – By Service Type 20 1.3.2 North America Healthcare contract research organizations (CRO) services Market – By Therapeutic Indication 20 1.3.3 North America Healthcare contract research organizations (CRO) services Market – By End User 21 1.3.4 North America Healthcare contract research organizations (CRO) services Market – By Country 21 2. North America Healthcare contract research organizations (CRO) services Market – Key Takeaways 22 3. Research Methodology 26 3.1 Coverage 27 3.2 Secondary Research 28 3.3 Primary Research 29 4. North America Healthcare contract research organizations (CRO) services Market – Market Landscape 30 4.1 Overview 30 4.2 PEST Analysis 31 4.2.1 Healthcare contract research organizations (CRO) services Market - North America PEST Analysis 31 4.3 Expert Opinion 32 5. North America Healthcare Contract Research Organizations (CRO) services Market - Key Market Dynamics 33 5.1 Key Market Drivers 33 5.1.1 Increasing Expenditure in R&D and Outsourcing Activities 33 5.1.1 Rising Number of Clinical Trials 34 5.2 Key Market Restraints 35 5.2.1 Stringent Regulations For Approval Of Drugs 35 5.3 Key Market Opportunities 35 5.3.1 Rising Biosimilars and Biologics Market 35 5.4 Future Trends 37 5.4.1 Globalization of Clinical Studies 37 5.5 Impact Analysis 37 6. Healthcare Contract Research Organizations (CRO) Services Market – North America Analysis 39 6.1 North America Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecasts and Analysis 39 7. North America Healthcare Contract Research Organizations (CRO) Services Market Analysis and Forecasts To 2027 – By Service Type 40 7.1 Overview 40 7.2 North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 40 7.2.1 North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027, By Service Type (US$ Mn) 41 7.2.2 Clinical-Research Services Market Revenue and Forecasts to 2027 (US$ Million) 42 7.2.3 Early Phase Development Market Revenue and Forecasts to 2027 (US$ Million) 42 7.2.4 Laboratory Services Market Revenue and Forecasts to 2027 (US$ Million) 43 7.3 Early Phase Development 44 7.3.1 Overview 44 7.3.2 North America Early Phase Development Market Revenue and Forecast to 2027 (US$ Mn) 44 7.3.3 Discovery Studies 45 7.3.3.1 Overview 45 7.3.3.2 North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 45 7.3.4 Chemistry, Manufacturing, and Control 47 7.3.4.1 Overview 47 7.3.4.2 North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 47 7.3.5 Pre-Clinical Services 49 7.3.5.1 Overview 49 7.3.5.2 North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 49 7.4 Laboratory Services 51 7.4.1 Overview 51 7.4.2 North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 51 7.4.3 Bio-analytical Testing 53 7.4.3.1 Overview 53 7.4.3.2 North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 53 7.4.4 Analytical Testing 54 7.4.4.1 Overview 54 7.4.4.2 North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 54 7.5 Consulting Services 55 7.5.1 Overview 55 7.5.2 North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 55 7.6 Clinical Research Services 56 7.6.1 Overview 56 7.6.2 North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 56 7.6.3 Phase I 58 7.6.3.1 Overview 58 7.6.3.2 North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 58 7.6.4 Phase II 59 7.6.4.1 Overview 59 7.6.4.2 North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 59 7.6.5 Phase III 60 7.6.5.1 Overview 60 7.6.5.2 North America Phase III Market Revenue and Forecasts to 2027 (US$ Mn) 60 7.6.6 Phase IV 61 7.6.6.1 Overview 61 7.6.6.2 North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 61 8. North America Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Therapeutic Application 63 8.1 Overview 63 8.2 North America Healthcare Contract Research Organizations (CRO) Services Market, By Therapeutic Application 2019-2027 (%) 63 8.2.1 North America Healthcare Contract Research Organizations (CRO) Services Market Devices Revenue and Forecasts to 2027, By Therapeutic Application (US$ Mn) 64 8.3 Oncology 66 8.3.1 Overview 66 8.3.2 North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 66 8.4 Infectious Diseases 68 8.4.1 Overview 68 8.4.2 North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 68 8.5 Cardiovascular Disease 70 8.5.1 Overview 70 8.5.2 North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 70 8.6 Respiratory Diseases 72 8.6.1 Overview 72 8.6.2 North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 72 8.7 Neurological Disorders 74 8.7.1 Overview 74 8.7.2 North America Neurological Disorders Market Revenue and Forecasts to 2027 (US$ Mn) 74 8.8 Others 76 8.8.1 Overview 76 8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 77 9. North America Healthcare contract research organizations (CRO) services Market Analysis – By End User 78 9.1 Overview 78 9.2 North America Healthcare contract research organizations (CRO) services Market, By End User 2019-2027 (%) 78 9.2.1 North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts to 2027, By End User (US$ Mn) 79 9.3 Pharmaceutical and Biopharmaceutical Companies 81 9.3.1 Overview 81 9.3.2 North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 81 9.4 Medical Device Companies 83 9.4.1 Overview 83 9.4.2 North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83 9.5 Others (Academic Institutes) 85 9.5.1 Overview 85 9.5.2 North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 85 10. Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 – Geographical Analysis 87 10.1 North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 87 10.1.1 Overview 87 10.1.2 North America: Healthcare Contract Research Organizations (CRO) Services Market-Revenue and Forecasts to 2027 (US$ Million) 89 10.1.3 North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 89 10.1.3.1 North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 90 10.1.3.2 North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 91 10.1.3.3 North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 92 10.1.4 North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 92 10.1.5 North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 93 10.1.6 North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 93 10.1.7 US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 95 10.1.7.1 US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 95 10.1.8 US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 96 10.1.8.1 US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 97 10.1.8.2 US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 97 10.1.8.3 US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 98 10.1.9 US Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 99 10.1.10 US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 99 10.1.11 Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 101 10.1.11.1 Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 101 10.1.12 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 102 10.1.12.1 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 103 10.1.12.2 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 104 10.1.12.3 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 104 10.1.13 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 105 10.1.14 Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 105 10.1.15 Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 107 10.1.15.1 Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 107 10.1.16 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 108 10.1.16.1 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 109 10.1.16.2 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 109 10.1.16.3 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 110 10.1.17 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 111 10.1.18 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 111 11. Impact of COVID-19 Pandemic on North America Healthcare contract research organizations (CRO) services Market 113 11.1 North America: Impact Assessment of COVID-19 Pandemic 113 12. Company Profiles 115 12.1 Charles River Laboratories, Inc. 115 12.1.1 Key Facts 115 12.1.2 Business Description 115 12.1.3 Products and Services 116 12.1.4 Financial Overview 117 12.1.5 SWOT Analysis 120 12.1.6 Key Developments 120 12.2 IQVIA INC. 122 12.2.1 Key Facts 122 12.2.2 Business Description 122 12.2.3 Products and Services 122 12.2.4 Financial Overview 124 12.2.5 SWOT Analysis 127 12.2.6 Key Developments 127 12.3 Laboratory Corporation of America Holdings(Covance) 129 12.3.1 Key Facts 129 12.3.2 Business Description 129 12.3.3 Products and Services 129 12.3.4 Financial Overview 130 12.3.5 SWOT Analysis 133 12.3.6 Key Developments 134 12.4 Parexel International Corporation 135 12.4.1 Key Facts 135 12.4.2 Business Description 135 12.4.3 Products and Services 136 12.4.4 Financial Overview 136 12.4.5 SWOT Analysis 136 12.4.6 Key Developments 138 12.5 PRA Health Sciences 139 12.5.1 Key Facts 139 12.5.2 Business Description 139 12.5.3 Products and Services 140 12.5.4 Financial Overview 141 12.5.5 SWOT Analysis 143 12.5.6 Key Developments 143 12.6 Syneos Health 145 12.6.1 Key Facts 145 12.6.2 Business Description 145 12.6.3 Products and Services 145 12.6.4 Financial Overview 146 12.6.5 SWOT Analysis 148 12.6.6 Key Developments 149 12.7 Medpace 151 12.7.1 Key Facts 151 12.7.2 Business Description 151 12.7.3 Products and Services 151 12.7.4 Financial Overview 152 12.7.5 SWOT Analysis 154 12.7.6 Key Developments 154 12.8 PPD Inc. 155 12.8.1 Key Facts 155 12.8.2 Business Description 155 12.8.3 Products and Services 155 12.8.4 Financial Overview 156 12.8.5 SWOT Analysis 158 12.8.6 Key Developments 158 13. Appendix 160 13.1 About 160 13.2 Glossary of Terms 160
LIST OF TABLES
Table 1. Number of registered Studies For Clinical Trials 36 Table 2. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Service Type (US$ Mn) 43 Table 3. Clinical-Research Services Market Revenue And Forecasts to 2027 (US$ Million) 44 Table 4. Early Phase Development Market Revenue And Forecasts to 2027 (US$ Million) 44 Table 5. Laboratory Services Market Revenue And Forecasts to 2027 (US$ Million) 45 Table 6. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Therapeutic Application (US$ Mn) 66 Table 7. North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027, By End User (US$ Mn) 81 Table 8. North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 91 Table 9. North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 92 Table 10. North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 93 Table 11. North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 94 Table 12. North America Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 94 Table 13. North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 95 Table 14. US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 98 Table 15. US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 99 Table 16. US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 100 Table 17. US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 100 Table 18. US Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 101 Table 19. US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 101 Table 20. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 104 Table 21. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 105 Table 22. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 106 Table 23. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 106 Table 24. Canada Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 107 Table 25. Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 108 Table 26. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 110 Table 27. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 111 Table 28. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 111 Table 29. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 112 Table 30. Mexico Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 113 Table 31. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 113 Table 32. Glossary of Terms, Healthcare Contract Research Organizations (CRO) Services Market 162
LIST OF FIGURES
Figure 1. Healthcare contract research organizations (CRO) services Market Segmentation 23 Figure 2. North America Healthcare contract research organizations (CRO) services Market Overview 26 Figure 3. Clinical Research Services Segment Held Largest Share of Healthcare Contract Research Organizations (CRO) Services Market 27 Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period 28 Figure 5. North America Healthcare contract research organizations (CRO) services Market - Leading Country Markets (US$ Mn) 29 Figure 6. Healthcare contract research organizations (CRO) services Market - North America PEST Analysis 35 Figure 1. Number of Approvals for NDA and BLA (2005 to 2019) 39 Figure 2. Healthcare contract research organizations (CRO) services Market Impact Analysis of Driver and Restraints 41 Figure 3. North America Healthcare Contract Research Organizations (CRO) Services market – Revenue Forecasts and Analysis – 2019- 2027 43 Figure 4. North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 44 Figure 5. North America Early Phase Development Market Revenue and Forecasts to 2027 (US$ Mn) 48 Figure 6. North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 49 Figure 7. North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 52 Figure 8. North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 53 Figure 9. North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 56 Figure 10. North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 57 Figure 11. North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 58 Figure 12. North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 59 Figure 13. North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 60 Figure 14. North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 62 Figure 15. North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 63 Figure 16. North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 64 Figure 17. North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 65 Figure 18. North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Application 2019 & 2027 (%) 67 Figure 19. North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 71 Figure 20. North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 73 Figure 21. North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 75 Figure 22. North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 77 Figure 23. North America Neurological Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 79 Figure 24. North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 81 Figure 25. North America Healthcare contract research organizations (CRO) services Market, by End User 2019 & 2027 (%) 82 Figure 26. North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 86 Figure 27. North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 88 Figure 28. North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 90 Figure 29. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue, by Country, 2019 (US$ Mn) 91 Figure 30. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Million) 93 Figure 31. North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 98 Figure 32. US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 100 Figure 33. Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 105 Figure 34. Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 111 Figure 35. Impact of COVID-19 Pandemic in North American Country Markets 117
Company Profiles
- Charles River Laboratories, Inc.
- IQVIA INC
- Laboratory Corporation of America Holdings (Covance)
- Parexel International Corporation
- PRA Health Sciences
- Syneos Health
- Medpace
- PPD Inc